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hsAno4     768   GIWYGILEGIGILSVITNAFVIAITSDFI    797 
rnAno4     768   GIWYGILEGIGILSVITNAFVIAITSDFI    797 
mmAno4     768   GIWYGILEGIGILSVITNAFVIAITSDFI    797 
btAno4     733   GIWYGILEGIGILSVITNAFVIAITSDFI    762 
ecAno4     781   GIWYGILEGIGILSVITNAFVIAITSDFI    810 
ggAno4     775   GIWYGILEGIGILSVITNAFVIAVTSDFI    804 
laAno4     794   GIWYGILEGIGILSVITNAFVIAITSDFI    823 
mamuAno4   768   GIWYGILEGIGILSVITNAFVIAITSDFI    797 
 
hsAno1 724 GLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRP 
rnAno1 777 GLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRP 
mmAno1 754 GLTPEYMEMIIQFGFVTLFVASFPLAPLFALLNNIIEIRLDAKKFVTELRRP 
hsAno2 740 GLTPEYMEMIIQFGFVTLFVASFPLAPVFALLNNVIEVRLDAKKFVTELRRP 
rnAno2 738 GLTPEYMEMIIQFGFVTLFVASFPLAPVFALLNNVIEVRLDAKKFVTELRRP 
mmAno2 738 GLTPEYMEMIIQFGFVTLFVASFPLAPVFALLNNVIEVRLDAKKFVTELRRP 
hsAno4 708 GLFDEYLEMILQFGFTTIFVAAFPLAPLLALLNNIIEIRLDAYKFVTQWRRP 
rnAno4 708 GLFDEYLEMILQFGFTTIFVAAFPLAPLLALLNNIIEIRLDAYKFVTQWRRP 
mmAno4   708  GLFDEYLEMILQFGFTTIFVAAFPLAPLLALLNNIIEIRLDAYKFVTQWRRP 
 
 
hsAno1 776 VAVRAKDIGIWYNILRGIGKLAVIINAFVISFTSDFIPRLVYLYMYSKNG-- 
rnAno1 830 VAIRAKDIGIWYNILRGVGKLAVIINAFVISFTSDFIPRLVYLYMYSQNG-- 
mmAno1 807 VAIRAKDIGIWYNILRGVGKLAVIINAFVISFTSDFIPRLVYLYMYSQNG-- 
hsAno2 793 DAVRTKDIGIWFDILSGIGKFSVISNAFVIAITSDFIPRLVYQYSYSHNG-- 
rnAno2 791 DAVRTKDIGIWFDILSGIGKFSVIINAFVIAVTSDFIPRLVYQYSYSHNG-- 
mmAno2 791 DAVRTKDIGIWFDILSGIGKFSVIINAFVIAVTSDFIPRLVYQYSYSHNG-- 
hsAno4 760 LASRAKDIGIWYGILEGIGILSVITNAFVIAITSDFIPRLVYAYKYGPCAGQ 
rnAno4 760 LASRAKDIGIWYGILEGIGILSVITNAFVIAITSDFIPRLVYAYKYGPCAGQ 
mmAno4 760 LASRAKDIGIWYGILEGIGILSVITNAFVIAITSDFIPRLVYAYKYGPCAGQ 
 
 
hsAno1 828 ------TMHGFVNHTLSSFNVSDFQNGTAPND 
rnAno1   882 ------TMHGFVNHTLSSFNVSDFQNGTAPND 
mmAno1 859 ------TMHGFVNHTLSSFNVSDFQNGTAPND 
hsAno2 845 ------TLHGFVNHTLSFFNVSQLKEGTQPEN 
rnAno2   843 ------TLHGFVNHTLSFFNVSQLKEGTQPEN  
mmAno2 843 ------TLHGFVNHTLSFFNVSQLKEGTQPEN  
hsAno4 812 GEAGQKCMVGYVNASLSVFRISDFENRSEPES 
rnAno4 812 GEAGQKCMVGYVNASLSVFRISDFENRSEPES 

































































































































































































































Supplement Table1:   
 
 
Supplement Table1: detailed amino acid sequence information of Ano1, 2 and 4 
name, species, accession number and number of amino acids. hs = homo sapiens; mm= mus musculus; 
rn = rattus norvegicus; bt = bos taurus; eq = equus caballus; gg = gallus gallus; la = loxodonta africana; 
mamu = macaca mulatta 
 
Name Species Accession number Length in amino acids 
hsAno4 
 
Homo sapiens NP_001273544.1 955 
mmAno4 
 
Mus musculus NP_001264117.1 955 
rnAno4 
 
Rattus norvegicus XP_008763453.1 955 
btAno4 
 
Bos taurus NP_001095520.1 920 





Gallus gallus XP_425452.4 962 
laAno4 
 
Loxodonta africana XP_003405674.1 981 
mamuAno4 
 
Macaca mulatta XP_001090523.1 955 
hsAno2 
 
Homo sapiens NP_001265525.1 1003 
mmAno2 
 
Mus musculus NP_705817.2 1002 
rnAno2 
 
Rattus norvegicus XP_008761521.1 1002 





Mus musculus NP_848757.4 1017 
rnAno1  
 
Rattus norvegicus NP_001101034.1 1040 
Supplement Figure 1: Electrophysiological analysis of heterologously expressed GFP and Ano2 
 
S1A: Confocal image of HEK cells expressing YFP. Staining with antibody against GFP (green). Scale 
bar represents 10μm. S1B: Raw currents through HEK293 cells heterologously expressing YFP before 
and after application of ionomycin (1μM), indicated by the bar. S1C: Current density-voltage plot of 
HEK293 cells heterologously expressing YFP before (filled circles) and after application of ionomycin 
(open circles). Values are given as mean ±SEM. S1D: Confocal image of HEK293 cells expressing Ano2- 
c-Myc. staining with antibody against c-Myc (red). Scale bar represents 10μm. S1E: Raw currents 
through HEK293 cells heterologously expressing Ano2 before and after application of ionomycin 
(1μM), indicated by the bar. S1F: Current density-voltage plot of HEK293 cells heterologously 
expressing Ano2 before (filled circles) and after application of ionomycin (open circles). S1G: Reversal 
potentials of the data shown in C (left) and F (right) before (black bars) and after (grey bars) 
application of ionomycin). S1H: Raw currents through HEK293 cells heterologously expressing Ano2 
before and after application of Ringer-NMDG, indicated by the bar. S1I: Current density-voltage plot 
of HEK293 cells heterologously expressing Ano2 before (filled circles) and after application of 
ionomycin (open circles). S1J: Currents evoked in transfected HEK cells by ionomycin: left panel: cell 
transfected with Ano4-1-1150del-GFP that lacks the N-terminus of Ano4; right panel cell transfected 
with Ano4-GFP that contains a GFP at the C-terminus. S1K: Confocal image of untransfected HEK293 
cells. Staining with antibodies against Ano4 (green) and pan Cadherin(red). Scale bar represents 
20μm. S1L: left side: Currents evoked in untransfected HEK cells (upper panel) by ATP and Hek cells 
transfected with GFP (lower panel) by ionomycin. Right side: Bar chart of total current density 
increase after the application of ATP in untransfected HEK293 cells (black bar) or ionomycin in 
HEK293 cells transfected with GFP (grey bar) normalized to current density before ATP stimulation 
(=1). All values are given as mean ±SEM. **: p<0.01. 
 
Supplement Figure 2: Lack of Scramblase activity of heterologously expressed Ano4 after 
stimulation with ATP 
 
S2A-C: Assessment of scramblase activity by FACS sorting of annexin A5-labeled HEK293 cells 
transfected with GFP alone (A), with Ano4 plus GFP under control conditions (B) or 20 min after the 
application of ATP (500 μM). (C): X-axis: Fluorescence intensity of Anx A5-6S-IDCC (log); Y-axis: 
Fluorescence intensity of GFP (log). The right upper square represents the transfected, Annexin A5- 
positive cell fraction. 
 
Supplement Figure 3: Alignment of conserved domains of Ano1, 2 and 4 
 
S3A: Multiple sequence alignment of Ano4 in the region displayed in Figure 3B. For detailed sequence 
information see Table1. Highly conserved E (at position 775 in mmAno4) marked in green. S3B: 
Multiple sequence alignment of Anoctamin1, 2 and 4 in the area spanning from amino acid 708-843 
(according to Figure 3A). Conserved amino acids are marked in black. Negatively charged amino acids 
highlighted in green and positively charged amino acids in red. 
 
Supplement Figure 4: Subcellular localization of WT Ano4, E775G and E775K 
 
S4A-C: Confocal image of HEK cells expressing Ano4 (A), E775G (B) and E775K (C). Staining with 
antibody against pan-Cadherin, a cell surface marker (red, left panel), Ano4 (green, middle panel).right 
panel: Merge of the two channels. Scale bar represents 10μm. S4D: Pearson Correlation Coefficient 
(PCC) of Ano4 and pan-Cadherin in HEK cells transfected with WT Ano4 (black bar), E775G (grey bar) 
and E775K (white bar). n=11-14 S4E: Western Blot of biotinylated samples: lane 1: untransfected 
HEK293; lane2: HEK293 transfected with GFP; lane 3:HEK293 transfected with GFP; arrows indicate 
different protein sizes 
 
Supplement Figure 5: Evaluation of the Ano4 antibody 
 
S5A: Confocal image of a HEK293 cell transfected with Ano4-c-Myc. Staining against c-Myc (red) and 
Ano4 (green); merge of the channels (yellow). Nuclei were stained with DAPI. Scale bar represents 
10μm. 
 
Supplement Figure 6: Modulation of gene and protein expression of Ano4 by siANO4 
 
S6A: Bar chart comparing the relative expression of Ano4 mRNA in siRNA-transfected cells (grey bar) 
to scRNA (black bar) transfection. Ano4 expression in scRNA-transfected cells is normalized to 1. S6B: 
Western Blot analysis of lysates of ARPE-19 cells, either non-transfected (co) or transfected with scRNA 
or siANO4 using an antibody against Ano4. β-Actin served as loading control. (estimated protein size: 
Ano4 111kDa, β-Actin 42kDa). S6C: Densitometric analysis of S5B: Relative expression of Ano4 protein 
in siAno4-transfected (grey bar) to scRNA-transfected cells (black bar) resulting from Western Blot 
experiments. Ano4-expression of scRNA transfected cells was normalized to 1. n=3*: p<0.05. 
 
Supplemental Figure 7: Influence of ionomycin on membrane expression of Ano4 
 
S7A: Confocal images of HEK 293 cells heterologously expressing Ano4 after stimulation with control 
substance (PBS, upper panel) or ionomycin (1μM, lower panel for 5 min. Staining with antibody against 
pan-Cadherin, a cell surface marker (red, left panel), Ano4 (green, middle panel). Right panel: Merge 
of the channels. Nuclei were stained with DAPI. Scale bar represents 10μm. S7B: Bar chart depicting 
the increase in membrane expression of Ano4 upon ionomycin stimulation. Values are normalized to 
control. nPBS= 29; nionomycin =26. S7C: Confocal images of ARPE 19 cells endogenously expressing Ano4 
after stimulation with control substance (PBS, upper panel) or ionomycin (1μM, lower panel for 5 min. 
Staining with antibody against ZO-1, a cell surface marker (red, left panel), Ano4 (green, middle panel). 
Right panel: Merge of the channels. Nuclei were stained with DAPI. Scale bar represents 10μm. S7D: 
Bar chart depicting the increase in membrane expression of Ano4 upon ionomycin stimulation. Values 
are normalized to control. nPBS= 12; nionomycin =20. 
